Several TLR ligands, including imiquimod (TLR7) and CpG (TLR9), have shown significant promise for the treatment of cancer (Kanzler et al, 2007; Smits et al, 2008; Wang et al, 2008). This evidence concerns the gene TLR9 and cancer.